| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 67028 |
Intravitreal injection of a pharmacologic agent |
7,980 |
4,212 |
$293K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
896 |
418 |
$284K |
| 92134 |
|
12,144 |
7,195 |
$91K |
| J9035 |
Injection, bevacizumab, 10 mg |
2,703 |
1,334 |
$61K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,153 |
1,332 |
$52K |
| J0178 |
Injection, aflibercept, 1 mg |
93 |
56 |
$42K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,380 |
848 |
$24K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
210 |
149 |
$12K |
| 92250 |
|
98 |
68 |
$2K |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
52 |
41 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
161 |
116 |
$0.00 |
| 5010F |
|
68 |
53 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
127 |
88 |
$0.00 |
| 2022F |
|
69 |
54 |
$0.00 |
| 4040F |
|
107 |
75 |
$0.00 |
| G8397 |
Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy |
54 |
40 |
$0.00 |
| 1036F |
|
149 |
113 |
$0.00 |